Related Experiment Videos
Managing prednisone in clients with chronic obstructive pulmonary disease
Nurse Practitioner Forum
|March 1, 1993
Summary
Prednisone can improve airflow for some patients with chronic obstructive pulmonary disease (COPD). A trial is recommended to assess benefits and risks before determining long-term treatment strategies.
Area of Science:
- Pulmonology
- Pharmacology
Background:
- Chronic obstructive pulmonary disease (COPD) is a progressive lung disease.
- Effective management strategies for COPD are crucial.
- Prednisone is a corticosteroid with potential benefits but also risks.
Purpose of the Study:
- To evaluate the efficacy of prednisone in improving airflow in COPD patients.
- To establish criteria for initiating and continuing prednisone therapy in COPD management.
Main Methods:
- Administering a steroid trial of prednisone to selected COPD individuals.
- Assessing subjective patient-reported improvements.
- Monitoring objective improvements via pulmonary function tests.
Main Results:
- Prednisone demonstrated improvement in airflow in a subset of COPD patients.
- Subjective and objective measures are key to treatment decisions.
- Identifying a suitable maintenance dose is important for ongoing benefit and risk mitigation.
Conclusions:
- A prednisone trial is a recommended initial step for selected COPD patients.
- Treatment continuation should be guided by demonstrated patient benefit.
- Optimizing prednisone dosage is essential to balance therapeutic effects with adverse effects.